Hamilton, OH, United States of America

Roy Lee Dobson


Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Fairfield, OH (US) (1989)
  • Hamilton, OH (US) (1994 - 2002)

Company Filing History:


Years Active: 1989-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Roy Lee Dobson

Introduction

Roy Lee Dobson is a notable inventor based in Hamilton, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address inflammation and pain. With a total of 3 patents to his name, Dobson's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among his latest patents is the invention of 5-(2-imidazolinylamino)-benzimidazole derivatives, which serve as .alpha.-adrenoceptor agonists with improved metabolic stability. Another significant patent involves a compound known as 4-(3,5-bis(1,1-dimethylethyl-4-hydroxyphenyl)-4-oxobutanamide). This invention includes compositions that comprise the aforementioned compound and methods for treating diseases characterized by inflammation and/or pain, such as rheumatoid arthritis and osteoarthritis, in both humans and lower animals.

Career Highlights

Roy Lee Dobson is currently employed at The Procter & Gamble Company, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to improving health outcomes through scientific research and development.

Collaborations

Throughout his career, Dobson has collaborated with notable colleagues, including Maurice E Loomans and Randall Stryker Matthews. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Roy Lee Dobson's contributions to the field of pharmaceuticals exemplify the impact of innovation in medicine. His patents reflect a dedication to addressing critical health issues, and his work continues to inspire advancements in treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…